172 related articles for article (PubMed ID: 18038919)
1. A double-blinded, randomized, placebo-controlled trial of infliximab in subjects with active pulmonary sarcoidosis.
Rossman MD; Newman LS; Baughman RP; Teirstein A; Weinberger SE; Miller W; Sands BE
Sarcoidosis Vasc Diffuse Lung Dis; 2006 Oct; 23(3):201-8. PubMed ID: 18038919
[TBL] [Abstract][Full Text] [Related]
2. C-reactive protein predicts response to infliximab in patients with chronic sarcoidosis.
Sweiss NJ; Barnathan ES; Lo K; Judson MA; Baughman R;
Sarcoidosis Vasc Diffuse Lung Dis; 2010 Jul; 27(1):49-56. PubMed ID: 21086905
[TBL] [Abstract][Full Text] [Related]
3. The potential additional benefit of infliximab in patients with chronic pulmonary sarcoidosis already receiving corticosteroids: a retrospective analysis from a randomized clinical trial.
Judson MA; Baughman RP; Costabel U; Mack M; Barnathan ES
Respir Med; 2014 Jan; 108(1):189-94. PubMed ID: 24361164
[TBL] [Abstract][Full Text] [Related]
4. Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement.
Baughman RP; Drent M; Kavuru M; Judson MA; Costabel U; du Bois R; Albera C; Brutsche M; Davis G; Donohue JF; Müller-Quernheim J; Schlenker-Herceg R; Flavin S; Lo KH; Oemar B; Barnathan ES;
Am J Respir Crit Care Med; 2006 Oct; 174(7):795-802. PubMed ID: 16840744
[TBL] [Abstract][Full Text] [Related]
5. Beneficial effect of infliximab on refractory sarcoidosis.
Ørum M; Hilberg O; Krag S; Bendstrup E
Dan Med J; 2012 Dec; 59(12):A4535. PubMed ID: 23290282
[TBL] [Abstract][Full Text] [Related]
6. Long term follow-up of infliximab efficacy in pulmonary and extra-pulmonary sarcoidosis refractory to conventional therapy.
Russell E; Luk F; Manocha S; Ho T; O'Connor C; Hussain H
Semin Arthritis Rheum; 2013 Aug; 43(1):119-24. PubMed ID: 23332903
[TBL] [Abstract][Full Text] [Related]
7. Changes in chest roentgenogram of sarcoidosis patients during a clinical trial of infliximab therapy: comparison of different methods of evaluation.
Baughman RP; Shipley R; Desai S; Drent M; Judson MA; Costabel U; du Bois RM; Kavuru M; Schlenker-Herceg R; Flavin S; Lo KH; Barnathan ES;
Chest; 2009 Aug; 136(2):526-535. PubMed ID: 19395578
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial.
Judson MA; Baughman RP; Costabel U; Flavin S; Lo KH; Kavuru MS; Drent M;
Eur Respir J; 2008 Jun; 31(6):1189-96. PubMed ID: 18256069
[TBL] [Abstract][Full Text] [Related]
9. Early treatment of stage II sarcoidosis improves 5-year pulmonary function.
Pietinalho A; Tukiainen P; Haahtela T; Persson T; Selroos O;
Chest; 2002 Jan; 121(1):24-31. PubMed ID: 11796428
[TBL] [Abstract][Full Text] [Related]
10. [TNFα blocking agents and sarcoidosis: an update].
Toussirot E; Pertuiset E
Rev Med Interne; 2010 Dec; 31(12):828-37. PubMed ID: 20510487
[TBL] [Abstract][Full Text] [Related]
11. Infliximab for treating sarcoidosis patients, Portuguese experience.
Aguiar M; Marçal N; Mendes AC; Bugalho de Almeida A
Rev Port Pneumol; 2011; 17(2):85-93. PubMed ID: 21477572
[TBL] [Abstract][Full Text] [Related]
12. Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondylarthropathy.
Van Den Bosch F; Kruithof E; Baeten D; Herssens A; de Keyser F; Mielants H; Veys EM
Arthritis Rheum; 2002 Mar; 46(3):755-65. PubMed ID: 11920412
[TBL] [Abstract][Full Text] [Related]
13. The treatment of disc-herniation-induced sciatica with infliximab: one-year follow-up results of FIRST II, a randomized controlled trial.
Korhonen T; Karppinen J; Paimela L; Malmivaara A; Lindgren KA; Bowman C; Hammond A; Kirkham B; Järvinen S; Niinimäki J; Veeger N; Haapea M; Torkki M; Tervonen O; Seitsalo S; Hurri H
Spine (Phila Pa 1976); 2006 Nov; 31(24):2759-66. PubMed ID: 17108825
[TBL] [Abstract][Full Text] [Related]
14. Long-term efficacy and safety of infliximab in the treatment of ankylosing spondylitis: an open, observational, extension study of a three-month, randomized, placebo-controlled trial.
Braun J; Brandt J; Listing J; Zink A; Alten R; Burmester G; Golder W; Gromnica-Ihle E; Kellner H; Schneider M; Sörensen H; Zeidler H; Reddig J; Sieper J
Arthritis Rheum; 2003 Aug; 48(8):2224-33. PubMed ID: 12905476
[TBL] [Abstract][Full Text] [Related]
15. The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease.
Rennard SI; Fogarty C; Kelsen S; Long W; Ramsdell J; Allison J; Mahler D; Saadeh C; Siler T; Snell P; Korenblat P; Smith W; Kaye M; Mandel M; Andrews C; Prabhu R; Donohue JF; Watt R; Lo KH; Schlenker-Herceg R; Barnathan ES; Murray J;
Am J Respir Crit Care Med; 2007 May; 175(9):926-34. PubMed ID: 17290043
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory profile and response to anti-tumor necrosis factor therapy in patients with chronic pulmonary sarcoidosis.
Loza MJ; Brodmerkel C; Du Bois RM; Judson MA; Costabel U; Drent M; Kavuru M; Flavin S; Lo KH; Barnathan ES; Baughman RP
Clin Vaccine Immunol; 2011 Jun; 18(6):931-9. PubMed ID: 21508170
[TBL] [Abstract][Full Text] [Related]
17. Treatment of palmoplantar psoriasis with infliximab: a randomized, double-blind placebo-controlled study.
Bissonnette R; Poulin Y; Guenther L; Lynde CW; Bolduc C; Nigen S
J Eur Acad Dermatol Venereol; 2011 Dec; 25(12):1402-8. PubMed ID: 21349113
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary sarcoidosis.
Baughman RP
Clin Chest Med; 2004 Sep; 25(3):521-30, vi. PubMed ID: 15331189
[TBL] [Abstract][Full Text] [Related]
19. Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks.
Cohen SB; Emery P; Greenwald MW; Dougados M; Furie RA; Genovese MC; Keystone EC; Loveless JE; Burmester GR; Cravets MW; Hessey EW; Shaw T; Totoritis MC;
Arthritis Rheum; 2006 Sep; 54(9):2793-806. PubMed ID: 16947627
[TBL] [Abstract][Full Text] [Related]
20. First study of infliximab treatment in patients with chronic obstructive pulmonary disease.
van der Vaart H; Koëter GH; Postma DS; Kauffman HF; ten Hacken NH
Am J Respir Crit Care Med; 2005 Aug; 172(4):465-9. PubMed ID: 15937294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
